Page last updated: 2024-10-24

calmidazolium and Electron Transport Chain Deficiencies, Mitochondrial

calmidazolium has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 1 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, CS1
Han, ES1
Han, YS1
Bang, H1

Other Studies

1 other study available for calmidazolium and Electron Transport Chain Deficiencies, Mitochondrial

ArticleYear
Differential effect of calmodulin antagonists on MG132-induced mitochondrial dysfunction and cell death in PC12 cells.
    Brain research bulletin, 2005, Oct-15, Volume: 67, Issue:3

    Topics: Animals; Calcium; Calmodulin; Caspase 3; Caspases; Cell Count; Cell Death; Cell Size; Cell Survival;

2005
chemdatabank.com